These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 11914885

  • 1. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
    Reinhardt MJ, Joe A, von Mallek D, Zimmerlin M, Manka-Waluch A, Palmedo H, Krause TM.
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
    [Abstract] [Full Text] [Related]

  • 2. Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?
    Reinhardt MJ, Biermann K, Wissmeyer M, Juengling FD, Brockmann H, von Mallek D, Ezziddin S, Joe AY, Krause TM.
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):608-12. PubMed ID: 16541268
    [Abstract] [Full Text] [Related]

  • 3. [First results of radioiodine therapy of multifocal and disseminated thyroid gland autonomy and use of a TcTUs-adapted dose concept].
    Oexle C, Reinhardt M, Moser E.
    Nuklearmedizin; 1998 May; 37(6):192-6. PubMed ID: 9770712
    [Abstract] [Full Text] [Related]

  • 4. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
    Reinhardt M, Emrich D, Krause T, Bräutigam P, Nitzsche E, Blattmann H, Schümichen C, Moser E.
    Eur J Endocrinol; 1995 May; 132(5):550-6. PubMed ID: 7749494
    [Abstract] [Full Text] [Related]

  • 5. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
    Seeger T, Emrich D, Sandrock D.
    Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
    Reinhardt MJ, Brink I, Joe AY, Von Mallek D, Ezziddin S, Palmedo H, Krause TM.
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1118-24. PubMed ID: 12192554
    [Abstract] [Full Text] [Related]

  • 8. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH.
    Ann Acad Med Stetin; 2000 Sep; 46():109-21. PubMed ID: 11712298
    [Abstract] [Full Text] [Related]

  • 9. Scintigraphic evaluation of functional thyroidal autonomy.
    Meller J, Becker W.
    Exp Clin Endocrinol Diabetes; 1998 Sep; 106 Suppl 4():S45-51. PubMed ID: 9867196
    [Abstract] [Full Text] [Related]

  • 10. TcTU before and after exogeneous TSH suppression in diagnosing thyroid autonomy.
    Kreisig T, Pickardt CR, Kirsch CM, Knesewitsch P.
    Acta Med Austriaca; 1990 Sep; 17 Suppl 1():54-5. PubMed ID: 2167603
    [Abstract] [Full Text] [Related]

  • 11. Radioiodine treatment of hyperthyroidism in cats: results of 165 cats treated by an individualised dosing algorithm in Spain.
    Xifra P, Serrano SI, Peterson ME.
    J Feline Med Surg; 2022 Aug; 24(8):e258-e268. PubMed ID: 35748791
    [Abstract] [Full Text] [Related]

  • 12. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
    Langhammer HR, Laubenbacher C, Hirsch C, Klingele C, Spyra JL, Senekowitsch-Schmidtke R, Schwaiger M.
    Med Klin (Munich); 1999 Aug 15; 94(8):415-24. PubMed ID: 10495620
    [Abstract] [Full Text] [Related]

  • 13. [Global 99mTc uptake in the differential diagnosis of a normal thyroid,goiter with euthyroidism and thyroid autonomy in an area of iodine deficiency].
    Kreisig T, Pickardt CR, Horn K, Bechtner G, Vaitl C, Kirsch CM, Knesewitsch P.
    Nuklearmedizin; 1990 Jun 15; 29(3):113-9. PubMed ID: 2168038
    [Abstract] [Full Text] [Related]

  • 14. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
    Meller J, Becker W.
    Q J Nucl Med; 1999 Sep 15; 43(3):179-87. PubMed ID: 10568133
    [Abstract] [Full Text] [Related]

  • 15. Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters.
    Szumowski P, Rogowski F, Abdelrazek S, Kociura-Sawicka A, Sokolik-Ostasz A.
    Nucl Med Rev Cent East Eur; 2012 Apr 24; 15(1):7-13. PubMed ID: 23047567
    [Abstract] [Full Text] [Related]

  • 16. Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate.
    Meller J, Wisheu S, Munzel U, Behe M, Gratz S, Becker W.
    Eur J Nucl Med; 2000 Sep 24; 27(9):1286-91. PubMed ID: 11007508
    [Abstract] [Full Text] [Related]

  • 17. EVALUATION OF QUANTITATIVE THYROID SCINTIGRAPHY FOR DIAGNOSIS AND STAGING OF DISEASE SEVERITY IN CATS WITH HYPERTHYROIDISM: COMPARISON OF THE PERCENT THYROIDAL UPTAKE OF PERTECHNETATE TO THYROID-TO-SALIVARY RATIO AND THYROID-TO-BACKGROUND RATIOS.
    Peterson ME, Guterl JN, Rishniw M, Broome MR.
    Vet Radiol Ultrasound; 2016 Jul 24; 57(4):427-40. PubMed ID: 27062212
    [Abstract] [Full Text] [Related]

  • 18. Pertechnetate uptake in the prediction of early outcome after radioiodine therapy.
    Gimlette TM.
    Nuklearmedizin; 1989 Feb 24; 28(1):21-5. PubMed ID: 2540481
    [Abstract] [Full Text] [Related]

  • 19. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.
    Grosso M, Traino A, Boni G, Banti E, Della Porta M, Manca G, Volterrani D, Chiacchio S, AlSharif A, Borsò E, Raschillà R, Di Martino F, Mariani G.
    Cancer Biother Radiopharm; 2005 Apr 24; 20(2):218-23. PubMed ID: 15869459
    [Abstract] [Full Text] [Related]

  • 20. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
    Meller J, Becker W.
    Eur J Nucl Med Mol Imaging; 2002 Aug 24; 29 Suppl 2():S425-38. PubMed ID: 12192542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.